Literature DB >> 19726510

Exclusion of West Nile virus superinfection through RNA replication.

Gang Zou1, Bo Zhang, Pei-Yin Lim, Zhiming Yuan, Kristen A Bernard, Pei-Yong Shi.   

Abstract

Superinfection exclusion is the ability of an established viral infection to interfere with a second viral infection. Using West Nile virus (WNV) as a model, we show that replicating replicons in BHK-21 cells suppress subsequent WNV infection. The WNV replicon also suppresses superinfections of other flaviviruses but not nonflaviviruses. Mode-of-action analysis indicates that the exclusion of WNV superinfection occurs at the step of RNA synthesis. The continuous culturing of WNV in the replicon-containing cells generated variants that could overcome the superinfection exclusion. The sequencing of the selected viruses revealed mutations in structural (prM S90R or envelope E138K) and nonstructural genes (NS4a K124R and peptide 2K V9M). Mutagenesis analysis showed that the mutations in structural genes nonselectively enhance viral infection in both naïve and replicon-containing BHK-21 cells; in contrast, the mutations in nonstructural genes more selectively enhance viral replication in the replicon-containing cells than in the naïve cells. Mechanistic analysis showed that the envelope mutation functions through the enhancement of virion attachment to BHK-21 cells, whereas the 2K mutation (and, to a lesser extent, the NS4a mutation) functions through the enhancement of viral RNA synthesis. Furthermore, we show that WNV superinfection exclusion is reversible by the treatment of the replicon cells with a flavivirus inhibitor. The preestablished replication of the replicon could be suppressed by infecting the cells with the 2K mutant WNV but not with the wild-type virus. These results suggest that WNV superinfection exclusion is a result of competition for intracellular host factors that are required for viral RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726510      PMCID: PMC2772679          DOI: 10.1128/JVI.01205-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses.

Authors:  Jorge L Muñoz-Jordán; Maudry Laurent-Rolle; Joseph Ashour; Luis Martínez-Sobrido; Mundrigi Ashok; W Ian Lipkin; Adolfo García-Sastre
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.

Authors:  Francesc Puig-Basagoiti; Tia S Deas; Ping Ren; Mark Tilgner; David M Ferguson; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.

Authors:  Sonja M Best; Keely L Morris; Jeffrey G Shannon; Shelly J Robertson; Dana N Mitzel; Gregory S Park; Elena Boer; James B Wolfinbarger; Marshall E Bloom
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  West Nile virus inhibits the signal transduction pathway of alpha interferon.

Authors:  Ju-Tao Guo; Junpei Hayashi; Christoph Seeger
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Triaryl pyrazoline compound inhibits flavivirus RNA replication.

Authors:  Francesc Puig-Basagoiti; Mark Tilgner; Brett M Forshey; Sean M Philpott; Noel G Espina; David E Wentworth; Scott J Goebel; Paul S Masters; Barry Falgout; Ping Ren; David M Ferguson; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication.

Authors:  Young-Min Lee; Donna M Tscherne; Sang-Im Yun; Ilya Frolov; Charles M Rice
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4.

Authors:  Nico Michel; Ina Allespach; Stephanie Venzke; Oliver T Fackler; Oliver T Keppler
Journal:  Curr Biol       Date:  2005-04-26       Impact factor: 10.834

8.  Measles virus superinfection immunity and receptor redistribution in persistently infected NT2 cells.

Authors:  Martin Ludlow; Stephen McQuaid; S Louise Cosby; Roberto Cattaneo; Bert K Rima; W Paul Duprex
Journal:  J Gen Virol       Date:  2005-08       Impact factor: 3.891

Review 9.  Retroviral superinfection resistance.

Authors:  Micha Nethe; Ben Berkhout; Antoinette C van der Kuyl
Journal:  Retrovirology       Date:  2005-08-18       Impact factor: 4.602

10.  A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor.

Authors:  Gang Zou; Francesc Puig-Basagoiti; Bo Zhang; Min Qing; Liqiang Chen; Krzysztof W Pankiewicz; Krzysztof Felczak; Zhiming Yuan; Pei-Yong Shi
Journal:  Virology       Date:  2008-12-05       Impact factor: 3.616

View more
  52 in total

1.  Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly.

Authors:  Xuping Xie; Jing Zou; Chunya Puttikhunt; Zhiming Yuan; Pei-Yong Shi
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Determinants of Dengue Virus NS4A Protein Oligomerization.

Authors:  Chia Min Lee; Xuping Xie; Jing Zou; Shi-Hua Li; Michelle Yue Qi Lee; Hongping Dong; Cheng-Feng Qin; Congbao Kang; Pei-Yong Shi
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

3.  A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.

Authors:  Na Li; Zhe-Rui Zhang; Ya-Nan Zhang; Jing Liu; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Han-Qing Ye; Bo Zhang
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

4.  Mosquitoes Transmit Unique West Nile Virus Populations during Each Feeding Episode.

Authors:  Nathan D Grubaugh; Joseph R Fauver; Claudia Rückert; James Weger-Lucarelli; Selene Garcia-Luna; Reyes A Murrieta; Alex Gendernalik; Darci R Smith; Doug E Brackney; Gregory D Ebel
Journal:  Cell Rep       Date:  2017-04-25       Impact factor: 9.423

5.  Internally deleted WNV genomes isolated from exotic birds in New Mexico: function in cells, mosquitoes, and mice.

Authors:  Kendra N Pesko; Kelly A Fitzpatrick; Elizabeth M Ryan; Pei-Yong Shi; Bo Zhang; Niall J Lennon; Ruchi M Newman; Matthew R Henn; Gregory D Ebel
Journal:  Virology       Date:  2012-02-23       Impact factor: 3.616

6.  Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles.

Authors:  Shilin Yuan; Guiming Li; Ying Wang; Qianqian Gao; Yizhuo Wang; Rui Cui; Ralf Altmeyer; Gang Zou
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

7.  Many human RNA viruses show extraordinarily stringent selective constraints on protein evolution.

Authors:  Jinn-Jy Lin; Maloyjo Joyraj Bhattacharjee; Chun-Ping Yu; Yan Yuan Tseng; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

8.  Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.

Authors:  Na Li; Ya-Nan Zhang; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Bo Zhang
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

9.  On the Fly: Interactions Between Birds, Mosquitoes, and Environment That Have Molded West Nile Virus Genomic Structure Over Two Decades.

Authors:  Nisha K Duggal; Kate E Langwig; Gregory D Ebel; Aaron C Brault
Journal:  J Med Entomol       Date:  2019-10-28       Impact factor: 2.278

10.  Orally co-Infected Aedes albopictus from La Reunion Island, Indian Ocean, can deliver both dengue and chikungunya infectious viral particles in their saliva.

Authors:  Marie Vazeille; Laurence Mousson; Estelle Martin; Anna-Bella Failloux
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.